Cardium’s Innercool Therapies Unit Announces Publication Of Positive Effects Of Early And Rapid Hypothermia Following Heart Attack
Cardium Therapeutics (Amex: CXM) and its operating unit InnerCool Therapies announced that positive findings from a preclinical study, demonstrating a new and expanded benefit of early rapid hyperthermia (cooling) for the potential treatment of acute myocardial infarction (heart attack), has been published online by BioMed Central (BMC) Cardiovascular Disorders (2008, 8:7, April 10, 2008).
More: continued here
Filed under: Cardiovascular on April 17th, 2008